{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:38:23Z","timestamp":1787243903554,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Modena e Reggio Emilia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To characterize, using real-life data, the clinical profile of men undergoing their first bone health evaluation at a tertiary academic center over a 14-year period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective, observational, cross-sectional study including adult men referred to our center between 2007 and 2021 for bone health assessment. Fractures, comorbidities, risk factors for bone loss, and pharmacological treatments were collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>536 men were enrolled (147 under 50, 385 over 50). At least one comorbidity associated with bone loss was found in 49.3% of patients, and 43.8% were receiving medications causing bone mineral density (BMD) reduction\u2014mainly corticosteroids and androgen deprivation therapy. The prevalence of osteoporosis, osteopenia, and low BMD for age was 42.3%, 44.8%, and 48.6%, respectively. Osteoporosis-related fractures were found in 216 patients (40.8%), whose 34 men under 50 (15.7%). Up to 17.5% of men with fractures had normal BMD. A total of 181 patients (33.8%) had never received calcium\/vitamin D supplementation or bone-active therapy; the prevalence of treatment-na\u00efve patients was 20\u201323% even among men with fractures or receiving corticosteroids\/androgen-deprivation therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Male osteoporosis presents with a high rate of fractures in the real-life clinical practice at a tertiary academic center. The high prevalence of comorbidities associated with bone loss suggests that secondary forms of osteoporosis should be carefully investigated, even in presence of normal BMD. The significant proportion of untreated men\u2014including those with known risk factors or fractures\u2014highlights the urgent need to raise awareness and improve the management of male osteoporosis, especially in primary healthcare.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-025-02753-8","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T09:09:34Z","timestamp":1766999374000},"page":"653-664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Too late, too often: missed opportunities in male bone health: a real-world portrait from a 14-year specialist referral experience"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-5683","authenticated-orcid":false,"given":"Sara","family":"De Vincentis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Taliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ansaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Domenici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Demichelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2881-982X","authenticated-orcid":false,"given":"Bruno","family":"Madeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8169-0696","authenticated-orcid":false,"given":"Vincenzo","family":"Rochira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"2753_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00012-2","author":"T Vilaca","year":"2022","unstructured":"Vilaca T, Eastell R, Schini M (2022) Osteoporosis in men. Lancet Diabetes Endocrinol 10(4):273\u2013283. https:\/\/doi.org\/10.1016\/S2213-8587(22)00012-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2753_CR2","first-page":"65","volume":"7","author":"T Willson","year":"2015","unstructured":"Willson T, Nelson SD, Newbold J, Nelson RE, LaFleur J (2015) The clinical epidemiology of male osteoporosis: a review of the recent literature. Clin Epidemiol 7:65\u201376","journal-title":"Clin Epidemiol"},{"key":"2753_CR3","unstructured":"Adler RA (2000) Updated 2024 Mar 26) osteoporosis in Men, endotext [Internet]. South Dartmouth (MA): MDText.com. Inc. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK558007\/"},{"key":"2753_CR4","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s00198-024-07236-9","volume":"35","author":"AN Khan","year":"2024","unstructured":"Khan AN, Jones RB Jr., Khan N, Yang YX, Adler RA (2024) Trends in hip fracture rates in US male veterans. Osteoporos Int 35:2137\u20132144","journal-title":"Osteoporos Int"},{"key":"2753_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/165215","volume":"2015","author":"V Rochira","year":"2015","unstructured":"Rochira V, Kara E, Carani C (2015) The endocrine role of estrogens on human male skeleton. Int J Endocrinol 2015:165215","journal-title":"Int J Endocrinol"},{"key":"2753_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1530\/eje.1.02088","volume":"154","author":"V Rochira","year":"2006","unstructured":"Rochira V, Balestrieri A, Madeo B, Zirilli L, Granata AR et al (2006) Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology. Eur J Endocrinol 154:175\u2013185","journal-title":"Eur J Endocrinol"},{"key":"2753_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","volume":"152","author":"P Haentjens","year":"2010","unstructured":"Haentjens P, Magaziner J, Col\u00f3n-Emeric CS, Vanderschueren D, Milisen K et al (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152:380\u2013390","journal-title":"Ann Intern Med"},{"key":"2753_CR8","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","volume":"353","author":"JR Center","year":"1999","unstructured":"Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878\u2013882","journal-title":"Lancet"},{"key":"2753_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12891-021-03960-z","volume":"22","author":"JP Brown","year":"2021","unstructured":"Brown JP, Adachi JD, Schemitsch E, Tarride JE, Brown V et al (2021) Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario. BMC Musculoskelet Disord 22:105","journal-title":"BMC Musculoskelet Disord"},{"key":"2753_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jama.2009.50","volume":"301","author":"D Bliuc","year":"2009","unstructured":"Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA et al (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513\u2013521","journal-title":"JAMA"},{"key":"2753_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/endrev\/bnab028","volume":"43","author":"PR Ebeling","year":"2022","unstructured":"Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P et al (2022) Secondary osteoporosis. Endocr Rev 43:240\u2013313","journal-title":"Endocr Rev"},{"key":"2753_CR12","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1056\/NEJMcp0707217","volume":"358","author":"PR Ebeling","year":"2008","unstructured":"Ebeling PR (2008) Clinical practice. Osteoporosis in men. N Engl J Med 358:1474\u20131482","journal-title":"N Engl J Med"},{"key":"2753_CR13","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s11154-022-09738-5","volume":"23","author":"K David","year":"2022","unstructured":"David K, Narinx N, Antonio L, Evenepoel P, Claessens F et al (2022) Bone health in ageing men. Rev Endocr Metab Disord 23:1173\u20131208","journal-title":"Rev Endocr Metab Disord"},{"key":"2753_CR14","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00198-010-1421-0","volume":"22","author":"CS Ryan","year":"2011","unstructured":"Ryan CS, Petkov VI, Adler RA (2011) Osteoporosis in men: the value of laboratory testing. Osteoporos Int 22:1845\u20131853","journal-title":"Osteoporos Int"},{"key":"2753_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11657-021-00915-8","volume":"16","author":"G Adami","year":"2021","unstructured":"Adami G, Gatti D, Rossini M, Giollo A, Bertoldo E et al (2021) Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset. Arch Osteoporos 16:56","journal-title":"Arch Osteoporos"},{"key":"2753_CR16","first-page":"305","volume":"2","author":"B Madeo","year":"2007","unstructured":"Madeo B, Zirilli L, Caffagni G, Diazzi C, Sanguanini A et al (2007) The osteoporotic male: overlooked and undermanaged? Clin Interv Aging 2:305\u2013312","journal-title":"Clin Interv Aging"},{"key":"2753_CR17","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1210\/jc.2011-3045","volume":"97","author":"NB Watts","year":"2012","unstructured":"Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R et al (2012) Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97:1802\u20131822","journal-title":"J Clin Endocrinol Metab"},{"key":"2753_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/andr.12470","volume":"6","author":"V Rochira","year":"2018","unstructured":"Rochira V, Antonio L, Vanderschueren D (2018) EAA clinical guideline on management of bone health in the andrological outpatient clinic. Andrology 6:272\u2013285","journal-title":"Andrology"},{"key":"2753_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S2213-8587(20)30408-3","volume":"9","author":"The Lancet Diabetes E","year":"2021","unstructured":"The Lancet Diabetes E (2021) Osteoporosis: overlooked in men for too long. Lancet Diabetes Endocrinol 9:1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2753_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","volume":"8","author":"E Hernlund","year":"2013","unstructured":"Hernlund E, Svedbom A, Iverg\u00e5rd M, Compston J, Cooper C et al (2013) Osteoporosis in the European union: medical management, epidemiology and economic burden. A report prepared in collaboration with the international osteoporosis foundation (IOF) and the European federation of pharmaceutical industry associations (EFPIA). Arch Osteoporos 8:136","journal-title":"Arch Osteoporos"},{"key":"2753_CR21","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1530\/EJE-20-0034","volume":"183","author":"T Porcelli","year":"2020","unstructured":"Porcelli T, Maffezzoni F, Pezzaioli LC, Delbarba A, Cappelli C et al (2020) Management of endocrine disease: male osteoporosis: diagnosis and management - should the treatment and the target be the same as for female osteoporosis? Eur J Endocrinol 183:R75-r93","journal-title":"Eur J Endocrinol"},{"key":"2753_CR22","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1210\/jc.2009-0417","volume":"94","author":"PM Cawthon","year":"2009","unstructured":"Cawthon PM, Ensrud KE, Laughlin GA, Cauley JA, Dam TT et al (2009) Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab 94:3806\u20133815","journal-title":"J Clin Endocrinol Metab"},{"key":"2753_CR23","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1210\/jc.2011-3058","volume":"97","author":"MT Drake","year":"2012","unstructured":"Drake MT, Murad MH, Mauck KF, Lane MA, Undavalli C et al (2012) Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 97:1861\u20131870","journal-title":"J Clin Endocrinol Metab"},{"key":"2753_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11657-021-01016-2","volume":"16","author":"H Wu","year":"2021","unstructured":"Wu H, Sun Z, Tong L, Wang Y, Yan H (2021) Bibliometric analysis of global research trends on male osteoporosis: a neglected field deserves more attention. Arch Osteoporos 16:154","journal-title":"Arch Osteoporos"},{"key":"2753_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3\u201344","journal-title":"Osteoporos Int"},{"key":"2753_CR26","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/andr.310","volume":"3","author":"V Rochira","year":"2015","unstructured":"Rochira V, Diazzi C, Santi D, Brigante G, Ansaloni A et al (2015) Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study. Andrology 3:298\u2013308","journal-title":"Andrology"},{"key":"2753_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jocd.2015.06.013","volume":"18","author":"JA Shepherd","year":"2015","unstructured":"Shepherd JA, Schousboe JT, Broy SB, Engelke K, Leslie WD (2015) Executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD. J Clin Densitom 18:274\u2013286","journal-title":"J Clin Densitom"},{"key":"2753_CR28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.maturitas.2013.05.013","volume":"75","author":"J Compston","year":"2013","unstructured":"Compston J, Bowring C, Cooper A, Cooper C, Davies C et al (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National osteoporosis guideline group (NOGG) update 2013. Maturitas 75:392\u2013396","journal-title":"Maturitas"},{"key":"2753_CR29","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s00198-011-1632-z","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Bianchi G, Bilezikian JP, Kaufman JM, Khosla S et al (2011) Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int 22:2789\u20132798","journal-title":"Osteoporos Int"},{"key":"2753_CR30","unstructured":"Foundation NO (2010) Clinician\u2019s guide to prevention and treatment of osteoporosis. Washington, DC Nafional Osteoporosis Foundafion"},{"key":"2753_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/ard.59.4.269","volume":"59","author":"SF Evans","year":"2000","unstructured":"Evans SF, Davie MW (2000) Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men. Ann Rheum Dis 59:269\u2013275","journal-title":"Ann Rheum Dis"},{"key":"2753_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg208","author":"SR Pye","year":"2003","unstructured":"Pye SR, Adams KR, Halsey JP, Klimiuk P, Knight SM et al (2003) Frequency and causes of osteoporosis in men. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/keg208","journal-title":"Rheumatology"},{"key":"2753_CR33","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1359\/jbmr.2003.18.4.784","volume":"18","author":"DA Hanley","year":"2003","unstructured":"Hanley DA, Brown JP, Tenenhouse A, Olszynski WP, Ioannidis G et al (2003) Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res 18:784\u2013790","journal-title":"J Bone Miner Res"},{"key":"2753_CR34","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00774-018-0981-5","volume":"37","author":"C Horii","year":"2019","unstructured":"Horii C, Asai Y, Iidaka T, Muraki S, Oka H et al (2019) Differences in prevalence and associated factors between mild and severe vertebral fractures in Japanese men and women: the third survey of the ROAD study. J Bone Miner Metab 37:844\u2013853","journal-title":"J Bone Miner Metab"},{"key":"2753_CR35","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s00223-021-00868-7","volume":"109","author":"JJ Carey","year":"2021","unstructured":"Carey JJ, Yang L, Erjiang E, Wang T, Gorham K et al (2021) Vertebral fractures in Ireland: a sub-analysis of the DXA HIP project. Calcif Tissue Int 109:534\u2013543","journal-title":"Calcif Tissue Int"},{"key":"2753_CR36","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00198-005-1950-0","volume":"16","author":"AC Feldstein","year":"2005","unstructured":"Feldstein AC, Nichols G, Orwoll E, Elmer PJ, Smith DH et al (2005) The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int 16:953\u2013962","journal-title":"Osteoporos Int"},{"key":"2753_CR37","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1007\/s00198-021-05976-6","volume":"32","author":"M Casella","year":"2021","unstructured":"Casella M, Becciolini A, Di Donato E, Basaglia M, Zardo M et al (2021) Internal medicine inpatients\u2019 prevalence of misdiagnosed severe osteoporosis. Osteoporos Int 32:2361\u20132364","journal-title":"Osteoporos Int"},{"key":"2753_CR38","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/bju.14075","volume":"121","author":"PS Kirk","year":"2018","unstructured":"Kirk PS, Borza T, Shahinian VB, Caram MEV, Makarov DV et al (2018) The implications of baseline bone-health assessment at initiation of androgen-deprivation therapy for prostate cancer. BJU Int 121:558\u2013564","journal-title":"BJU Int"},{"key":"2753_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1530\/eje.1.02254","volume":"155","author":"V Rochira","year":"2006","unstructured":"Rochira V, Zirilli L, Genazzani AD, Balestrieri A, Aranda C et al (2006) Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback. Eur J Endocrinol 155:513\u2013522","journal-title":"Eur J Endocrinol"},{"key":"2753_CR40","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.4158\/EP-2020-0123","volume":"26","author":"P Choksi","year":"2020","unstructured":"Choksi P, Gay BL, Reyes-Gastelum D, Haymart MR, Papaleontiou M (2020) Understanding osteoporosis screening practices in men: a nationwide physician survey. Endocr Pract 26:1237\u20131243","journal-title":"Endocr Pract"},{"key":"2753_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/MLR.0000000000001459","volume":"59","author":"MK Pasquale","year":"2021","unstructured":"Pasquale MK, Sheer RL, Yehoshua A, McFadden A, Chines A et al (2021) Evaluation of an osteoporosis outreach program for men with a fragility fracture and their physicians. Med Care 59:148\u2013154","journal-title":"Med Care"},{"key":"2753_CR42","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.6004\/jnccn.2020.7576","volume":"18","author":"J Hu","year":"2020","unstructured":"Hu J, Aprikian AG, Vanhuyse M, Dragomir A (2020) Contemporary population-based analysis of bone mineral density testing in men initiating androgen deprivation therapy for prostate cancer. J Natl Compr Canc Netw 18:1374\u20131381","journal-title":"J Natl Compr Canc Netw"},{"key":"2753_CR43","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac129","volume":"6","author":"T Goettemoeller","year":"2022","unstructured":"Goettemoeller T, Bena J, Pantalone KM (2022) Lack of bone mineral density testing in men with hypogonadism: a clinical conundrum. J Endocr Soc 6:bvac129","journal-title":"J Endocr Soc"},{"key":"2753_CR44","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/jbmr.3182","volume":"32","author":"N Binkley","year":"2017","unstructured":"Binkley N, Blank RD, Leslie WD, Lewiecki EM, Eisman JA et al (2017) Osteoporosis in crisis: it\u2019s time to focus on fracture. J Bone Miner Res 32:1391\u20131394","journal-title":"J Bone Miner Res"},{"key":"2753_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ando.2022.01.002","volume":"83","author":"R Litke","year":"2022","unstructured":"Litke R, Puisieux F, Paccou J, Beuscart JB, Delabriere I (2022) A retrospective study on the etiological exploration of osteoporosis in aging men in a French geriatric setting. Ann Endocrinol (Paris) 83:109\u2013113","journal-title":"Ann Endocrinol (Paris)"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02753-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02753-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02753-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:14:26Z","timestamp":1774419266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02753-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["2753"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02753-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the North Emilia Vast Area (AVEN) Ethics Committee (approval n. 268\/2021\/OSS\/AOUMO) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by SDV, AR, AA, ET, DD, GDA, VD, BM, and VR. The first draft of the manuscript was written by SDV and VR and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contribution statements"}}]}}